Literature DB >> 18303228

A comparative study of bimatoprost and travoprost: effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients.

Gürsoy Alagoz1, Kamil Gürel, Atilla Bayer, Didem Serin, Serdal Celebi, Sahap Kukner.   

Abstract

BACKGROUND: This study compares intraocular pressure (IOP)-lowering efficacy and retrobulbar hemodynamic effects of bimatoprost and travoprost in patients with newly diagnosed open-angle glaucoma.
METHODS: Patients were randomly assigned to one of two treatment groups (bimatoprost group, n = 36; travoprost group, n = 46). IOP levels were measured with Goldmann applanation tonometer. Peak systolic velocity, end-diastolic velocity and resistivity index were obtained for each vessel by color Doppler imaging.
RESULTS: Both bimatoprost and travoprost significantly lowered IOP on days 30, 90 and 180 (p < 0.001). There was no significance between the 2 drugs on all follow-up visits. End-diastolic velocity of central retinal artery on day 180 was significantly higher than the value obtained at baseline in both groups.
CONCLUSIONS: Patients were likely to achieve and maintain low target IOP with both drugs. Both drugs also resulted in improvement in the central retinal artery blood flow. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303228     DOI: 10.1159/000112624

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  9 in total

1.  Macular perfusion in healthy Chinese: an optical coherence tomography angiogram study.

Authors:  Jian Yu; Chunhui Jiang; Xiaolei Wang; Li Zhu; Ruiping Gu; Huan Xu; Yali Jia; David Huang; Xinghuai Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

2.  Intraocular pressure, blood pressure, and retinal blood flow autoregulation: a mathematical model to clarify their relationship and clinical relevance.

Authors:  Giovanna Guidoboni; Alon Harris; Simone Cassani; Julia Arciero; Brent Siesky; Annahita Amireskandari; Leslie Tobe; Patrick Egan; Ingrida Januleviciene; Joshua Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-29       Impact factor: 4.799

Review 3.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

4.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30

Review 5.  Bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Ocular blood flow as a clinical observation: Value, limitations and data analysis.

Authors:  Alon Harris; Giovanna Guidoboni; Brent Siesky; Sunu Mathew; Alice C Verticchio Vercellin; Lucas Rowe; Julia Arciero
Journal:  Prog Retin Eye Res       Date:  2020-01-24       Impact factor: 21.198

7.  Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy.

Authors:  Steven M Kymes; Caroline Burk; Todd Feinman; Julia M Williams; David A Hollander
Journal:  Ther Clin Risk Manag       Date:  2011-07-12       Impact factor: 2.423

8.  Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients.

Authors:  Wissam Georges El Hajj Moussa; Rebecca Georges Farhat; Joseph Claud Nehme; Marwan Antoun Sahyoun; Alexandre Raymond Schakal; Alexandre Edmond Jalkh; Mariana Pierre Abi Karam; Georges Georges Azar
Journal:  J Ophthalmol       Date:  2018-03-07       Impact factor: 1.909

9.  Macular Vascular Geometry Changes With Sex and Age in Healthy Subjects: A Fundus Photography Study.

Authors:  Ziqing Feng; Gengyuan Wang; Honghui Xia; Meng Li; Guoxia Liang; Tingting Dong; Peng Xiao; Jin Yuan
Journal:  Front Med (Lausanne)       Date:  2021-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.